Neurogenic Dyspnea: Is Idiopathic Dyspnea related to a post-viral sensory neuropathy? A Case Series Supporting a New Hypothesis
DOI:
https://doi.org/10.52845/JORR/2021/2.1.1Abstract
OBJECTIVE: To propose a hypothesis of a novel potentially post-viral sensory neuropathic disorder, termed neurogenic dyspnea, and assess the therapeutic efficacy of a trigger reduction approach in this unique
patient population.
METHODS: A retrospective chart review of patients seen between January 2011 and April 2018 for persistent dyspnea of unknown etiology was conducted. All patients failed to improve with treatment for presumptive diagnoses of allergy, asthma, sinus disease, and reflux. Patients were educated on our treatment protocol consisting of a Mediterranean style, plant-based diet with alkaline water, saline irrigation, and combined azelastine/fluticasone nasal spray. Treatment response was followed using two validated symptom questionnaires,
Reflux Symptom Index (RSI) and Dyspnea Index (DI).
RESULTS: Of 57 initial patients, 8 were included in the final analysis. Mean age was 38.8 years (range 11-68). Six (75%) patients were female. All patients were followed for a minimum of 4 weeks. Using the reduction in DI and RSI as continuous variables to assess response, patients experienced a 9.4 (95% CI: 3.9 – 14.9) and 14.1 (95% CI: 6.0 –22.2) mean point reduction, respectively. One patient saw a 100% and another a 95% reduction in DI. Six of eight patients experienced more than a 50% reduction in RSI.
CONCLUSION: We hypothesize that Neurogenic Dyspnea is a newly described clinical phenomenon with a possible post-viral etiology. This pilot study demonstrated that our trigger reduction approach improved subjective symptoms in the majority of patients with unexplained dyspnea with previous treatment failure for common etiologies. Further studies are required to validate these findings.
References
Hayen A, Herigstad M, Pattinson KTS. Understanding dyspnea as a complex individual experience. Maturitas. 2013;76(1):45–50. Available from: https://dx.doi.org/10.1016/j.maturitas. 2013.06.005. doi:10.1016/j.maturitas.2013.06.
Cukier-Blaj S, Bewley A, Aviv JE, Murry T. Paradoxical Vocal Fold Motion: A Sensory- Motor Laryngeal Disorder. The Laryngoscope. 2008;118(2):367–370. Available from: https:// dx.doi.org/10.1097/mlg.0b013e31815988b0. do i:10.1097/mlg.0b013e31815988b0.
Aaron SD, Vandemheen KL, Fitzgerald JM. Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. Jama. 2017;317(3):269–79.
Zalvan C, Berzofsky C, Tiwari R, Geliebter J. Trigger Reduction Prior to Systemic Drugs for Neurogenic Chronic Cough. The Laryngoscope. 2019;129(1):198–202. Available from: https:// dx.doi.org/10.1002/lary.27459. doi:10.1002/lar y.27459.
Zalvan C, Yuen E, Geliebter J, Tiwari R; 2019.
Zalvan CH, Hu S, Greenberg B, Geliebter J. A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux. JAMA Otolaryngology–Head & Neck Surgery. 2017;143(10):1023–1023. Available from: https://dx.doi.org/10.1001/jamaoto.2017. 1454. doi:10.1001/
jamaoto.2017.1454.
Nacci A, Fattori B, Segnini G, Dallan I, Panicucci E, Rocchi V, et al. Respiratory Retraining Therapy in Long-Term Treatment of Paradoxical Vocal Fold Dysfunction. Folia Phoniatrica et Logopaedica. 2011;63(3):134–141. Available from: https://dx.doi.org/10.1159/000316405. do i:10.1159/000316405.
Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough. Chest. 2016;149(3):639– 648. Available from: https://dx.doi.org/10.1378/ chest.15-1271. doi:10.1378/chest.15-1271.
Belafsky PC, Postma GN, Koufman JA. Validity and Reliability of the Reflux Symptom Index (RSI). Journal of Voice. 2002;16(2):274– 277. Available from: https://dx.doi.org/10.1016/ s0892-1997(02)00097-8. doi:10.1016/s0892-19
(02)00097-8.
Gartner-Schmidt JL, Shembel AC, Zullo TG, Rosen CA. Development and Validation of the Dyspnea Index (DI): A Severity Index for Upper Airway–Related Dyspnea. Journal of Voice. 2014;28(6):775–782. Available from: https://dx. doi.org/10.1016/j.jvoice.2013.12.017. doi:10.10 16/j.jvoice.2013.12.017.
Lien HC, Wang CC, Lee SW. Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance. Value Health. 2015;18(4):396–403.
Gray AJ, Huston M, Didericksen D, Meyer TK, Merati A, Brisebois S. The minimal clinically important difference of the dyspnea index in laryngotracheal stenosis. The Laryngoscope. 2020;130(7):1775–1779. Available from: https:
//dx.doi.org/10.1002/lary.28331. doi:10.1002/lary.28331.
Canning BJ, Chou YL. Cough sensors. I. Physiological and pharmacological properties of the afferent nerves regulating cough. Handb Exp Pharmacol. 2009;(187):23–47.
Lee LY. Respiratory sensations evoked by activation of bronchopulmonary C-fibers. Respir Physiol Neurobiol. 2009;167(1):26–35.
Soler ZM, Patel ZM, Turner JH, Holbrook EH. A primer on viral-associated olfactory loss in the era of COVID-19. International Forum of Allergy & Rhinology. 2020;10(7):814–820. Available from: https://dx.doi.org/10.1002/alr.22578.
doi:10.1002/alr.22578.
Brann DH, Tsukahara T, Weinreb C. Nonneuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31).
Bogaerts K, Notebaert K, Diest IV, Devriese S, Peuter SD, den Bergh OV. Accuracy of respiratory symptom perception in different affective contexts. Journal of Psychosomatic Research. 2005;58(6):537–543. Available from: https:// dx.doi.org/10.1016/j.jpsychores.2004.12.005. doi:10.1016/j.jpsychores.2004.12.005.
von Leupoldt A, Chan PYS, Bradley MM, Lang PJ, Davenport PW. The impact of anxiety on the neural processing of respiratory sensations. NeuroImage. 2011;55(1):247–252. Available from: https://dx.doi.org/10.1016/j.neuroimage.
11.050. doi:10.1016/j.neuroimage.2010.11.050.
Rosenkranz MA, Davidson RJ. Affective neural circuitry and mind–body influences in asthma. NeuroImage. 2009;47(3):972–980. Available from: https://dx.doi.org/10.1016/j.neuroimage. 2009.05.042. doi:10.1016/j.neuroimage.2009.05.042.
Nowobilski R, Furgał M, Polczyk R, Barbaro BD, Szczeklik A. Gender gap in psychogenic factors may affect perception of asthma symptoms. J Investig Allergol Clin Immunol. 2011;21(3):193–201.
Undem BJ, Nassenstein C. Airway nerves and dyspnea associated with inflammatory airway disease. Respiratory Physiology & Neurobiology. 2009;167(1):36–44. Available from: https: //dx.doi.org/10.1016/j.resp.2008.11.012. doi:10
.1016/j.resp.2008.11.012.
Lin RL, Gu Q, Lin YS, Lee LY. Stimulatory effect of CO2 on vagal bronchopulmonary Cfiber afferents during airway inflammation. J Appl Physiol. 1985;99(5):1704–1715.
Omar S, Clarke R, Abdullah H. Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells. PLoS One. 2017;12(2):171681–171681.
Mazzone SB, Undem BJ. Vagal Afferent Innervation of the Airways in Health and Disease. Physiological Reviews. 2016;96(3):975– 1024. Available from: https://dx.doi.org/10. 1152/physrev.00039.2015. doi:10.1152/physrev .00039.2015.
Marcinow AM, Thompson J, Forrest LA, de- Silva BW. Irritant-Induced Paradoxical Vocal Fold Motion Disorder. Otolaryngology–Head and Neck Surgery. 2015;153(6):996–1000. Available from: https://dx.doi.org/10. 1177/0194599815600144. doi:10.1177/0194599815600144.
Soni RS, Ebersole B, Jamal N. Treatment of Chronic Cough: Single-Institution Experience Utilizing Behavioral Therapy. SAGE Publications; 2017. Available from: https://dx.doi.org/ 10.1177/0194599816675299. doi:10.1177/0194 599816675299.
Greene SM, Simpson CB. Evidence for Sensory Neuropathy and Pharmacologic Management. Otolaryngologic Clinics of North America. 2010;43(1):67–72. Available from: https: //dx.doi.org/10.1016/j.otc.2009.11.003. doi:10.
/j.otc.2009.11.003.
Park KH, Choi SM, Kwon SU, Yoon SW, Kim SU. Diagnosis of laryngopharyngeal reflux among globus patients. Otolaryngol Head Neck Surg. 2006;134(1):81–86.
